Abstract
The complement system is a part of the immune system implicated in host defense against pathogens and damaged cells and Factor H is the main regulatory protein of this powerful enzymatic cascade. Autoantibodies directed against Factor H (anti-FH antibodies) are implicated in different pathologies mainly atypical hemolytic and uremic syndrome and C3 glomerulopathies. The detection and quantification of these autoantibodies are crucial for the clinical management of the patients.
Anti-Factor H antibodies are detected and quantified by an ELISA assay. The aim of this chapter is to describe the procedure to determine anti-FH autoantibodies and to provide information about their biological significance.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dragon-Durey M-A, Loirat C, Cloarec S et al (2005) Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome. J Am Soc Nephrol 16:555–563. https://doi.org/10.1681/ASN.2004050380
Jokiranta TS, Solomon A, Pangburn MK et al (1999) Nephritogenic lambda light chain dimer: a unique human miniautoantibody against complement factor H. J Immunol 163:4590–4596
Blanc C, Togarsimalemath SK, Chauvet S et al (2015) Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases. J Immunol 194:5129–5138. https://doi.org/10.4049/jimmunol.1402770
Foltyn Zadura A, Zipfel PF, Bokarewa MI et al (2012) Factor H autoantibodies and deletion of complement factor H-related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome. Arthritis Res Ther 14:R185. https://doi.org/10.1186/ar4016
Foltyn Zadura A, Memon AA, Stojanovich L et al (2015) Factor H autoantibodies in patients with antiphospholipid syndrome and thrombosis. J Rheumatol 42:1786–1793. https://doi.org/10.3899/jrheum.150185
Dragon-Durey M-A, Blanc C, Roumenina LT et al (2014) Anti-factor H autoantibodies assay. Methods Mol Biol 1100:249–256. https://doi.org/10.1007/978-1-62703-724-2_20
Dragon-Durey M-A, Senant M (2015) Method for in vitro quantifying allo-antibodies, auto-antibodies and/or therapeutic antibodies. International Application No. PCT/IB2014/064437. Pub. No. WO/2015/036956, issued March 19, 2015
Dragon-Durey M-A, Frémeaux-Bacchi V, Loirat C et al (2004) Heterozygous and homozygous Factor H deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases. J Am Soc Nephrol 15:787–795. https://doi.org/10.1097/01.ASN.0000115702.28859.A7
Sánchez-Corral P, González-Rubio C, Rodríguez de Córdoba S, López-Trascasa M (2004) Functional analysis in serum from atypical Hemolytic Uremic Syndrome patients reveals impaired protection of host cells associated with mutations in factor H. Mol Immunol 41:81–84. https://doi.org/10.1016/j.molimm.2004.01.003
Durey MA, Sinha A, Togarsimalemath SK, Bagga A (2016) Anti-complement-factor H-associated glomerulopathies. Nat Rev Nephrol 12(9):563–578. https://doi.org/10.1038/nrneph.2016.99
Dragon-Durey M-A, Blanc C, Marliot F et al (2009) The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome. J Med Genet 46:447–450. https://doi.org/10.1136/jmg.2008.064766
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Sénant, M., Dragon-Durey, MA. (2019). Anti-factor H Autoantibodies Assay by ELISA. In: Houen, G. (eds) Autoantibodies. Methods in Molecular Biology, vol 1901. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8949-2_15
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8949-2_15
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8948-5
Online ISBN: 978-1-4939-8949-2
eBook Packages: Springer Protocols